Insulin-like growth factors.

D. LeRoith, M. McGuinness, J. Shemer, B. Stannard, F. Lanau, T. N. Faria, H. Kato, H. Werner, M. Adamo, Charles Roberts

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The insulin-like growth factors (IGF-I and IGF-II) play important roles in the regulation of growth and metabolism. While the liver is the main source of circulating IGFs, their production by numerous extrahepatic tissues suggests the existence of autocrine and paracrine modes of action in addition to typical endocrine mechanisms. The actions of the IGFs are mediated through their activation of specific cell surface receptors, primarily the IGF-I receptor, although some effects may be mediated through the IGF-II receptor and the insulin receptor. The stability of the IGFs and their interaction with their receptors are mediated by specific IGF binding proteins (IGF-BPs) which are found in the circulation and in extracellular fluids. Thus, the overall biological actions of the IGFs can be regulated by control of ligand biosynthesis, modulation of receptor levels and postreceptor signalling pathways, and changes in the levels and activity of IGF-BPs.

Original languageEnglish (US)
Pages (from-to)173-181
Number of pages9
JournalBiological Signals
Volume1
Issue number4
StatePublished - Jul 1992
Externally publishedYes

Fingerprint

IGF Type 2 Receptor
Insulin-Like Growth Factor Binding Proteins
IGF Type 1 Receptor
Insulin-Like Growth Factor II
Biosynthesis
Insulin Receptor
Cell Surface Receptors
Somatomedins
Insulin-Like Growth Factor I
Metabolism
Liver
Chemical activation
Modulation
Tissue
Ligands
Fluids
Extracellular Fluid
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

LeRoith, D., McGuinness, M., Shemer, J., Stannard, B., Lanau, F., Faria, T. N., ... Roberts, C. (1992). Insulin-like growth factors. Biological Signals, 1(4), 173-181.

Insulin-like growth factors. / LeRoith, D.; McGuinness, M.; Shemer, J.; Stannard, B.; Lanau, F.; Faria, T. N.; Kato, H.; Werner, H.; Adamo, M.; Roberts, Charles.

In: Biological Signals, Vol. 1, No. 4, 07.1992, p. 173-181.

Research output: Contribution to journalArticle

LeRoith, D, McGuinness, M, Shemer, J, Stannard, B, Lanau, F, Faria, TN, Kato, H, Werner, H, Adamo, M & Roberts, C 1992, 'Insulin-like growth factors.', Biological Signals, vol. 1, no. 4, pp. 173-181.
LeRoith D, McGuinness M, Shemer J, Stannard B, Lanau F, Faria TN et al. Insulin-like growth factors. Biological Signals. 1992 Jul;1(4):173-181.
LeRoith, D. ; McGuinness, M. ; Shemer, J. ; Stannard, B. ; Lanau, F. ; Faria, T. N. ; Kato, H. ; Werner, H. ; Adamo, M. ; Roberts, Charles. / Insulin-like growth factors. In: Biological Signals. 1992 ; Vol. 1, No. 4. pp. 173-181.
@article{771a2794f2ba43319aeb9fae0ca76a89,
title = "Insulin-like growth factors.",
abstract = "The insulin-like growth factors (IGF-I and IGF-II) play important roles in the regulation of growth and metabolism. While the liver is the main source of circulating IGFs, their production by numerous extrahepatic tissues suggests the existence of autocrine and paracrine modes of action in addition to typical endocrine mechanisms. The actions of the IGFs are mediated through their activation of specific cell surface receptors, primarily the IGF-I receptor, although some effects may be mediated through the IGF-II receptor and the insulin receptor. The stability of the IGFs and their interaction with their receptors are mediated by specific IGF binding proteins (IGF-BPs) which are found in the circulation and in extracellular fluids. Thus, the overall biological actions of the IGFs can be regulated by control of ligand biosynthesis, modulation of receptor levels and postreceptor signalling pathways, and changes in the levels and activity of IGF-BPs.",
author = "D. LeRoith and M. McGuinness and J. Shemer and B. Stannard and F. Lanau and Faria, {T. N.} and H. Kato and H. Werner and M. Adamo and Charles Roberts",
year = "1992",
month = "7",
language = "English (US)",
volume = "1",
pages = "173--181",
journal = "NeuroSignals",
issn = "1424-862X",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Insulin-like growth factors.

AU - LeRoith, D.

AU - McGuinness, M.

AU - Shemer, J.

AU - Stannard, B.

AU - Lanau, F.

AU - Faria, T. N.

AU - Kato, H.

AU - Werner, H.

AU - Adamo, M.

AU - Roberts, Charles

PY - 1992/7

Y1 - 1992/7

N2 - The insulin-like growth factors (IGF-I and IGF-II) play important roles in the regulation of growth and metabolism. While the liver is the main source of circulating IGFs, their production by numerous extrahepatic tissues suggests the existence of autocrine and paracrine modes of action in addition to typical endocrine mechanisms. The actions of the IGFs are mediated through their activation of specific cell surface receptors, primarily the IGF-I receptor, although some effects may be mediated through the IGF-II receptor and the insulin receptor. The stability of the IGFs and their interaction with their receptors are mediated by specific IGF binding proteins (IGF-BPs) which are found in the circulation and in extracellular fluids. Thus, the overall biological actions of the IGFs can be regulated by control of ligand biosynthesis, modulation of receptor levels and postreceptor signalling pathways, and changes in the levels and activity of IGF-BPs.

AB - The insulin-like growth factors (IGF-I and IGF-II) play important roles in the regulation of growth and metabolism. While the liver is the main source of circulating IGFs, their production by numerous extrahepatic tissues suggests the existence of autocrine and paracrine modes of action in addition to typical endocrine mechanisms. The actions of the IGFs are mediated through their activation of specific cell surface receptors, primarily the IGF-I receptor, although some effects may be mediated through the IGF-II receptor and the insulin receptor. The stability of the IGFs and their interaction with their receptors are mediated by specific IGF binding proteins (IGF-BPs) which are found in the circulation and in extracellular fluids. Thus, the overall biological actions of the IGFs can be regulated by control of ligand biosynthesis, modulation of receptor levels and postreceptor signalling pathways, and changes in the levels and activity of IGF-BPs.

UR - http://www.scopus.com/inward/record.url?scp=17544393005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544393005&partnerID=8YFLogxK

M3 - Article

C2 - 1307923

VL - 1

SP - 173

EP - 181

JO - NeuroSignals

JF - NeuroSignals

SN - 1424-862X

IS - 4

ER -